InvestorsHub Logo
Followers 70
Posts 11280
Boards Moderated 0
Alias Born 01/05/2018

Re: djs7 post# 397916

Saturday, 05/20/2023 8:18:59 PM

Saturday, May 20, 2023 8:18:59 PM

Post# of 402893
I thank you for that since I hope someone at IPIX at least looks into and acknowledges the idea about the program because in my mind and opinion it fits Brilacidin to a T.

For the FDA to reject Brilacidin to be used right now in the new oral formulation that Leo mentioned in the recent 10Q is ridiculous. The amount of pain and suffering it can potentially save someone who is undergoing Chemotherapy and Radiation treatment and is susceptible to get OM, is well worth the use. It also is a tremendous savings for the individuals and their medical insurance company because the cost to fight OM depending on its severity is tremendous.

Yes someone might say I am only bringing this up because it would also help IPIX financially since it would generate immediate revenue by way of sale of product to medical facilities but I truly am more concerned of not having to ever watch anyone else develop OM and watch how it debilitates and stops the cancer treatment in individuals who suffer from it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News